Fiche du document
- doi: 10.3389/fphys.2014.00522
- issn: 1664-042X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fphys.2014.00522
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25642192
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1664-042X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_62F93479F3D14
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Supposition AssumptionCiter ce document
L.A. Demetrius et al., « Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect. », Serveur académique Lausannois, ID : 10.3389/fphys.2014.00522
Métriques
Partage / Export
Résumé
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are characterized by the following hallmarks: (a) An exponential increase with age; (b) Selective neuronal vulnerability; (c) Inverse cancer comorbidity. The present article appeals to these hallmarks to evaluate and contrast two competing models of AD: the amyloid hypothesis (a neuron-centric mechanism) and the Inverse Warburg hypothesis (a neuron-astrocytic mechanism). We show that these three hallmarks of AD conflict with the amyloid hypothesis, but are consistent with the Inverse Warburg hypothesis, a bioenergetic model which postulates that AD is the result of a cascade of three events-mitochondrial dysregulation, metabolic reprogramming (the Inverse Warburg effect), and natural selection. We also provide an explanation for the failures of the clinical trials based on amyloid immunization, and we propose a new class of therapeutic strategies consistent with the neuroenergetic selection model.